首页> 外国专利> Pharmaceutical dosage forms of tizanidine and route of administration

Pharmaceutical dosage forms of tizanidine and route of administration

机译:替扎尼定的药物剂型和给药途径

摘要

A pharmaceutical composition of tizanidine in liquid form for use in therapy for intranasal administration characterized by containing active ingredient in its hydrochloride, dissolved in an aqueous solution and a buffer solution at a value selected pH in the range of 4.8 to 7.4, by the fact that the obtained solution, properly sterilized by heat treatment or a suitable preservative is added it can be administered as such or optionally added with one or more flavoring agents, tonicity agents, hyperbaric agents and enhancing agents suitable absorption commonly used.
机译:用于鼻内给药的液体形式的替扎尼定的药物组合物,其特征在于,其盐酸盐中含有活性成分,该活性成分溶解在水溶液和缓冲溶液中,其选定的pH值在4.8至7.4的范围内,加入通过热处理适当灭菌的所得溶液或合适的防腐剂,可以将其原样施用或任选地与一种或多种常用的适合吸收的调味剂,张度剂,高压剂和增强剂一起添加。

著录项

  • 公开/公告号ES2596359T3

    专利类型

  • 公开/公告日2017-01-09

    原文格式PDF

  • 申请/专利权人 MDM S.P.A.;

    申请/专利号ES20090425528T

  • 发明设计人 BORSA MASSIMILIANO;

    申请日2009-12-18

  • 分类号A61K9/08;A61K31/433;

  • 国家 ES

  • 入库时间 2022-08-21 13:35:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号